Enyedy Mark J 4

What Happened

• Mark J. Enyedy, a director of Charles River Laboratories International, Inc. (CRL), was granted 1,438 restricted stock units (RSUs) on 2026-05-08. The award is reported at $177.62 per share, for a total reported value of $255,418. This transaction is an award/acquisition (code A) — a compensation grant, not an open-market buy or sale.

Key Details

• Transaction date: 2026-05-08; Form 4 filed: 2026-05-11.
• Grant: 1,438 unvested RSUs at $177.62 per share; total value ≈ $255,418.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: RSUs vest upon the earlier of May 8, 2027 or the business day prior to the company’s next annual meeting of shareholders.
• Timeliness: Filing dated 2026-05-11 reports the 2026-05-08 grant; the provided data does not indicate a late-report legend.

Context

• RSUs are a form of equity compensation that convert to actual shares only upon vesting. This grant reflects routine director compensation rather than an immediate market purchase or sale, so it should be interpreted as compensation-related rather than a direct trading signal about Enyedy’s personal buying/selling intent.